SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of CareFusion Corporation -- CFN

STEVENSON, Md., Oct. 22, 2014 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Court of Chancery on behalf of all common stockholders of CareFusion Corporation ("CareFusion" or the "Company") CFN opposing the proposed acquisition of CareFusion by Becton, Dickinson and Company ("BD").

The complaint arises out of the October 5, 2014 announcement that CareFusion had entered into a definitive merger agreement with BD, pursuant to which CareFusion shareholders will receive $49.00 in cash and 0.0777 of a share of BD for each share of CareFusion common stock they own.

The complaint seeks relief on behalf of the named plaintiff and all other similarly situated shareholders of CareFusion and asserts whether the Company's Board of Directors breached their fiduciary duties by failing to maximize shareholder value and/or protect the interests of CareFusion shareholders. 

If you currently own common stock of CareFusion and would like to learn more about this lawsuit and your ability to participate as a plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.

CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 hoffman@browerpiven.com
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!